Institutional investors hold a majority ownership of SGEN through the 107.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2012, these large investors purchased a net $2.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.9 Million shares of Seattle Genetics Inc
ROCKEFELLER & CO., INC. Bought 1.4 Million shares of Seattle Genetics Inc